Turning Science into business
Dr Lynn Johnson Langer discusses getting biotech science out of the lab and into market
Published 31 July 2018
Back in the day, ‘applied life science’ might have referred only to winemaking.
Nowadays the massive biotechnology industry is responsible for a vast array of projects that fight diseases, find the functional age of cells, and even create effective alternatives to vaccines.
But, as Dr Lynn Johnson Langer warns, many of these exciting new projects will never leave the lab without the right funding and the development of relevant and in-depth business skills.
Episode recorded: July 18
Producers: Dr Andi Horvath, Chris Hatzis and Silvi Vann-Wall Audio engineer and editor: Chris Hatzis
Banner image: Henk Caspers/Naturalis Biodiversity Center
Subscribe to Eavesdrop on Experts through iTunes, SoundCloud or RSS.
Subscribe to Eavesdrop on Experts through iTunes.
